RNAi Therapeutics

Pages

▼
Showing posts with label DACC. Show all posts
Showing posts with label DACC. Show all posts
Monday, January 27, 2014

Silence Therapeutics DACC Lipoplexes for Lung Endothelial RNAi Delivery

›
After having shown for some time now deep and long-lasting gene knockdown in lung endothelial cells, Silence Therapeutics has finally pu...
Tuesday, September 27, 2011

Silence Therapeutics Signs Lung Delivery Deal with Mystery Partner

›
As Tekmira is struggling to regain possession over its delivery technology from mighty Alnylam, it is foremost Silence Therapeutics' bus...
2 comments:
Wednesday, September 7, 2011

Impressions from the Abstracts of the 7th Annual Meeting of the Oligonucleotide Therapeutics Society (Part 1)

›
The Annual Meetings of the Oligonucleotide Therapeutics Society are among the best on the conference circus related to, well, oligonucleotid...
›
Home
View web version
Powered by Blogger.